Is NMR a Buy or a Sell? The Bull and Bear Case (2026)

Last updated July 2026

Short answer

Both cases are real, which is why the question is contested. The bull case for Nomura Holdings (NMR) rests on Wealth Management is being rebuilt around recurring fees: Nomura has spent years converting a commission-driven retail brokerage into a fee-based asset gathering business, and fiscal 2026 was the division's best showing since it was created in 2002. The bear case rests on wholesale revenue is genuinely cyclical, and a year of record trading results is a poor guide to the next one; Nomura has posted losing years in this division within recent memory. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.

Nomura Holdings, Inc. is the parent of Japan's largest securities firm, founded in 1925 and organised under a holding company that listed on the NYSE in 2001. Four divisions carry the business as of the year ended March 2026. Wealth Management runs the domestic retail and high-net-worth franchise and produced net revenue of ~JPY 487.9 billion with income before income taxes of ~JPY 204.0 billion. Investment Management houses Nomura Asset Management, an aircraft leasing operation and a stake in American Century Investments, and ended the year with assets under management of ~JPY 136.9 trillion after completing the purchase of Macquarie Group's US and European public asset management business in December 2025. Wholesale, the largest unit at ~JPY 1,162.2 billion of net revenue, covers Global Markets and Investment Banking across Japan, the Americas, EMEA and Asia. Banking, established on April 1, 2025, is the newest and smallest piece at ~JPY 53.9 billion. Group net revenue reached ~JPY 2,167.7 billion for the fiscal year, up ~14.5%, with net income attributable to shareholders of ~JPY 362.1 billion (roughly $13.6 billion and $2.3 billion at ~JPY 159 per US dollar, the Federal Reserve H.10 rate for mid-August 2026). The investment picture rests on three things that do not always move together. First, Japanese retail activity and the shift of household savings out of deposits, which is what drives the Wealth Management recurring revenue base. Second, the global trading and advisory cycle, which is what makes Wholesale swing. Third, the yen, because every reported figure is translated before a US holder ever sees it. At ~$9.81 per ADS in mid-August 2026 the market capitalisation is ~$28.6 billion (~JPY 4.55 trillion) against ~JPY 3,707.9 billion of shareholders' equity, so the shares change hands near ~1.2 times book on trailing earnings of roughly ~12 times. Management has set targets for the fiscal year ending March 2030 of return on equity of 10% to 12% or better and income before income taxes above ~JPY 750 billion, and returned ~JPY 101.5 billion through buybacks in fiscal 2026 alongside a declared annual dividend of ~JPY 51 per share. Capital sits well above the regulatory floor, with a common equity Tier 1 ratio of ~12.86% at March 31, 2026 against an internal target of at least 11%.

The bull case for NMR

1. Wealth Management is being rebuilt around recurring fees

Nomura has spent years converting a commission-driven retail brokerage into a fee-based asset gathering business, and fiscal 2026 was the division's best showing since it was created in 2002. Recurring revenue and recurring revenue assets both hit records, and the recurring revenue cost coverage ratio reached 72% for the year before climbing to 76% in the June 2026 quarter. Higher coverage means a larger share of the division's fixed cost base is paid for by fees that arrive whether or not clients trade, which is what turns a cyclical retail unit into a steadier one.

2. Asset management scale after the Macquarie purchase

The December 2025 acquisition of Macquarie Group's US and European public asset management business added international distribution to a franchise that had been heavily Japanese, and it brought client relationship intangibles carried at ~JPY 112.7 billion that amortise over twelve years. Assets under management finished the fiscal year at a record ~JPY 136.9 trillion and reached ~JPY 156 trillion by June 30, 2026. Outflows were recorded inside the acquired book even as the group held net inflows of ~JPY 0.4 trillion overall, so retention at the purchased business is the number worth following.

3. Wholesale is finally covering its cost base

Wholesale has historically been where Nomura's returns went to die, absorbing capital without consistently clearing its expenses. Fiscal 2026 net revenue of ~JPY 1,162.2 billion produced income before income taxes of ~JPY 200.6 billion, an all-time high, and the June 2026 quarter set fresh records for both, with Investment Banking quarterly net revenue passing ~JPY 50 billion for the first time. Whether that persists through a quieter trading environment is the open question, since Global Markets revenue is the most volatile line the group reports.

4. Capital return policy and the 2030 arithmetic

Policy calls for dividends of at least 40% of each half-year's consolidated earnings and a total payout ratio including buybacks of at least 50%. Fiscal 2026 delivered ~JPY 51 per share in declared dividends plus ~JPY 101.5 billion of repurchases, and a program authorised on January 30, 2026 allows up to 100 million further shares through September 30, 2026. Share count has fallen from ~2.97 billion at March 2024 to ~2.90 billion at March 2026, which flatters per-share figures independently of earnings growth.

The bear case for NMR

Wholesale revenue is genuinely cyclical, and a year of record trading results is a poor guide to the next one; Nomura has posted losing years in this division within recent memory. Currency translation cuts both ways for a US holder, since a weaker yen shrinks reported dollar earnings and the ADR price even when the underlying yen business is unchanged. Legal and regulatory matters are long-running rather than acute: Note 22 of the fiscal 2026 annual report estimates aggregate reasonably possible losses beyond amounts already accrued at approximately JPY 62 billion, spanning Madoff-related clawback suits against Nomura International plc, two Italian civil claims tied to Banca Monte dei Paschi di Siena transactions, and a European Commission European Government Bonds competition fine reduced to about EUR 125.6 million on appeal in March 2025 and now before the Court of Justice. Separately, Japan's securities watchdog found rule violations in government bond futures trading in 2024, after which several plaintiff firms publicised investigations of potential claims; no securities-fraud class action against the company has been docketed, and the matter does not appear among the significant proceedings listed in the latest annual report. Domestic competition is intensifying from online brokers on retail commissions and from megabank-affiliated securities arms in wholesale, while a rising Japanese rate environment reprices both the funding book and the deposit-linked Banking Division in ways that have not yet been tested through a full cycle.

The bear case deserves the same attention as the bull case, and usually gets less. If you are holding NMR already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.

Where analysts land on NMR

Too few analysts publish on NMR for a consensus target to mean anything, so there is no professional average to weigh against your own view. That cuts both ways: less informed opinion to lean on, and less of it already priced in. The NMR forecast page covers what coverage does exist.

How is NMR valued? (as of August 2026)

Price

$9.81

Market cap

$28.67B

P/E (TTM)

11.68

Forward P/E

17.52

Price / book

1.19

Beta

0.60

52-week range

$6.71 to $10.06

Snapshot for NMR as of August 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.

Net revenue (FY ended March 2026): ~JPY 2,167.7B, up ~14.5% (~$13.6B at ~JPY 159 per USD)
Net income to shareholders (FY2026): ~JPY 362.1B (~$2.3B), diluted EPS ~JPY 118.99, ROE ~10.1%
Latest quarter (ended June 30, 2026): Net revenue ~JPY 686.7B (+31% YoY), pretax ~JPY 211.5B, ROE ~15.4%
Market cap: ~$28.6B (~JPY 4.55T) at ~$9.81 per ADS, ~2.90B shares outstanding
Valuation: ~12x trailing earnings, ~10.5x forward, ~1.2x book (equity ~JPY 3,707.9B)
Dividend and buybacks (FY2026): ~JPY 51 per share declared plus ~JPY 101.5B repurchased; policy is 40%+ payout, 50%+ total

All operating figures originate in Japanese yen and are translated here at ~JPY 159 per US dollar (Federal Reserve H.10, mid-August 2026); Nomura itself translated its June 2026 quarter at ~JPY 162.61, the New York noon buying rate on June 30, 2026, so published dollar equivalents vary with the rate chosen. One ADS equals one common share, which keeps the ADR arithmetic simple: the ~$28.6 billion capitalisation is just the Tokyo price converted. Quoted ADR dividend yields of roughly ~2.6% run below the ~3.3% implied by the JPY 51 declaration because ADR distributions arrive net of Japanese withholding tax and are converted at payment-date rates.

How do you decide if NMR is a buy?

Rather than asking whether NMR is a buy in the abstract, it tends to help to answer four questions:

Thesis: do you believe the bull case above, and is it still true today?
Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
Overlap: check whether you already hold NMR indirectly through an index or sector ETF before adding more.

What would change your mind on NMR

Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.

Bull case breaks if: Wealth Management is being rebuilt around recurring fees stalls in the reported numbers rather than in the narrative around them.
Bear case breaks if: wholesale revenue is genuinely cyclical, and a year of record trading results is a poor guide to the next one; Nomura has posted losing years in this division within recent memory fails to materialise over several reporting periods while the drivers keep compounding.
Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.

For the full picture, see the NMR stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about NMR against your real portfolio and see your actual exposure before deciding.

Investing in Nomura Holdings with AI

Connect the broker you already use and ask Walnut's AI how NMR fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.

See how it fits your portfolio

FAQ

Is NMR a good stock to buy right now?

That depends on which case you find more convincing, and both are on this page. The bull case rests on Wealth Management is being rebuilt around recurring fees, with net revenue (fy ended march 2026) at ~JPY 2,167.7B, up ~14.5% (~$13.6B at ~JPY 159 per USD). The bear case rests on wholesale revenue is genuinely cyclical, and a year of record trading results is a poor guide to the next one; Nomura has posted losing years in this division within recent memory. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Should I sell NMR?

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Wholesale revenue is genuinely cyclical, and a year of record trading results is a poor guide to the next one; Nomura has posted losing years in this division within recent memory. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. Walnut is not an investment adviser.

What is the bull case for NMR?

Wealth Management is being rebuilt around recurring fees. Nomura has spent years converting a commission-driven retail brokerage into a fee-based asset gathering business, and fiscal 2026 was the division's best showing since it was created in 2002.

What is the bear case for NMR?

What does Nomura Holdings do?

Nomura Holdings is Japan's largest brokerage and investment bank, listed in New York as an American depositary receipt.

What would have to change for NMR to stop being worth holding?

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Wealth Management is being rebuilt around recurring fees) stalling in the reported numbers rather than in the narrative, the risk above (wholesale revenue is genuinely cyclical, and a year of record trading results is a poor guide to the next one; Nomura has posted losing years in this division within recent memory) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

What does the NMR ticker actually represent?

NMR is an American Depositary Share of Nomura Holdings, Inc. traded on the New York Stock Exchange under Commission file number 1-15270. One ADS represents one Nomura common share, the same security listed in Tokyo under code 8604. As of March 31, 2026 there were 79,924,681 ADSs outstanding out of 2,901,337,224 total shares, so the US listing is a small slice of a mostly Japanese shareholder base.

Why are Nomura's revenue figures so large compared with its market cap?

Because they are reported in Japanese yen, not dollars. Fiscal 2026 net revenue of ~JPY 2,167.7 billion converts to roughly ~$13.6 billion at ~JPY 159 per US dollar. A raw yen figure read as though it were dollars overstates the business by a factor of about 159, which is a common error on data aggregators that strip the currency label. Nomura also reports a gross revenue line of ~JPY 4,758.5 billion that includes interest and dividends before interest expense of ~JPY 2,590.8 billion is deducted, so two different revenue numbers circulate for the same year.

How does the yen affect a US investor's return?

Directly and continuously. Nomura earns and reports in yen, and the ADS price tracks the Tokyo share price converted at the spot rate, so a 10% move in the yen moves a dollar-based return by roughly 10% before the business does anything. Dividends are declared in yen and converted at payment-date rates, which is one reason quoted ADR yields drift from the yen-denominated figure. The yen sat near ~159 per dollar in mid-August 2026 after several years of weakness.

Walnut is informational, not investment advice, and gives no verdict on NMR. Analyst targets referenced here come from a August 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.